Ann Anderson, MD
Clinical Pathology/Laboratory Medicine · Garden City, NYNPI 1154492247
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Roche Diagnostics Corporation at 31.5% of the total. That places this record below the midpoint for clinical pathology/laboratory medicine clinicians in NY, where the typical reported total is $151.
Across 7 payments — averaging $22.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Diagnostics Corporation$50
- Illumina, Inc.$45
- IBSA Pharma Inc.$25
- Myriad Genetic Laboratories, Inc.$24
- Genentech USA, Inc.$15
What the payments were for
- Food & beverage$158100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Diagnostics Corporation | 2 | $50 |
| Illumina, Inc. | 2 | $45 |
| IBSA Pharma Inc. | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $15 |
How this compares
$158 in reported general payments places this provider in the 50th percentile of 37 clinical pathology/laboratory medicine providers in New York.
See all clinical pathology/laboratory medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 13 | $376 |
| Omeprazole | 13 | $291 |
| Furosemide | 13 | $96 |
Paid to pharmacies, not to this prescriber.
Other clinical pathology/laboratory medicine in Garden City
- Anjali SaqiNew York$182K
- Melissa CushingNew York$139K
- Morayma Reyes GilBronx$28K
- Ahmet DoganNew York$25K
- Matthew GreenblattNew York$19K
- Michael PrystowskyBronx$5K
- Alexander KratzNew York$3K
- Daniel GreenNew York$3K
- Ila SinghNew York$2K
- Lawrence JohnsonFarmingdale$721
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.